Safety and feasibility of dobutamine stress echocardiography in patients with implantable cardioverter defibrillators

Research output: Contribution to journalArticle

4 Scopus citations

Abstract

Coronary artery disease is the underlying etiology of left ventricular dysfunction and arrhythmias in most patients who receive implantable cardioverter defibrillators (ICDs). The aim of this study was to assess the safety and feasibility of dobutamine stress echocardiography (DSE) in patients with an ICD. DSE (dobutamine up to 50 μg/kg/min, atropine up to 2 mg) was performed in 87 patients with an ICD and known or suspected coronary artery disease. The ICD was inactivated before the stress test and reactivated after the study; no serious complications occured. DSE is a safe and feasible method for evaluating myocardial ischemia in patients with an ICD.

Original languageEnglish (US)
Pages (from-to)475-477
Number of pages3
JournalAmerican Journal of Cardiology
Volume92
Issue number4
DOIs
StatePublished - Aug 15 2003

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Safety and feasibility of dobutamine stress echocardiography in patients with implantable cardioverter defibrillators'. Together they form a unique fingerprint.

  • Cite this